FRONTIERS IN BIOSCIENCE;

DATA FORM FOR CANCER STAGING - MALIGNANT MELANOMA OF THE CONJUNCTIVA





Form # 785-1-052

CLIN PATH DEFINITIONS
    PRIMARY TUMOR (T)

TX Primary tumor cannot be assessed

T0 No evidence of primary tumor

T1 Tumor(s) of bulbar conjunctiva occupying one quadrant or less

T2 Tumor(s) of bulbar conjunctiva occupying more than one quadrant

T3 Tumor(s) of conjunctival fornix and/or palpebral conjunctiva and/or caruncle

T4 Tumor invades eyelid, cornea, and/or orbit
    LYMPH NODE (N)

NX Regional lymph nodes cannot be assessed

N0 No regional lymph node metastasis

N1 Regional lymph node metastasis
    Distant Metastasis (M)

MX Presence of distant metastasis cannot be assessed

M0 No distant metastasis

M1 Distant Metastasis
    PRIMARY TUMOR (PT)

pTX Primary tumor cannot be assessed

pT0 No evidence of primary tumor

pT1 Tumor(s) of bulbar conjunctiva occupying one quadrant or less and 2 mm or less in thickness

pT2 Tumor(s) of bulbar conjunctiva occupying more than one quadrant and 2 mm or less ithickness

pT3 Tumor(s) of conjunctival fornix and/or palpebral conjunctiva and/or caruncle and/or tumor of the bulbar conjunctiva, more than 2 mm in thickness

pT4 Tumor invades eyelid, cornea, and/or orbit
    LYMPH NODE (PN)

pNX Regional lymph nodes cannot be assessed

pN0 No regional lymph node metastasis

pN1 Regional lymph node metastasis
    DISTANT METASTASIS (PM)

pMX Presence of distant metastasis cannot be assessed

pM0 No distant metastasis

pM1 Distant metastasis

Pathologic Stage by: M.D. Date:  

STAGE GROUPING

No stage grouping is presently recommended

THE FINAL STAGE GROUPING (CLINICAL & PATHOLOGICAL) IS THE RESPONSIBILITY OF THE ATTENDING PHYSICIAN.

 Comments:

Patient Name: